Orthofix Medical Inc (OFIX)
15.32
-0.06
(-0.42%)
USD |
NASDAQ |
Sep 27, 16:00
15.32
0.00 (0.00%)
After-Hours: 20:00
Orthofix Medical Research and Development Expense (Annual): 80.23M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 80.23M |
| December 31, 2022 | 49.06M |
| December 31, 2021 | 49.62M |
| December 31, 2020 | 39.06M |
| December 31, 2019 | 34.64M |
| December 31, 2018 | 33.22M |
| December 31, 2017 | 29.70M |
| December 31, 2016 | 28.80M |
| December 31, 2015 | 26.39M |
| December 31, 2014 | 24.99M |
| December 31, 2013 | 26.77M |
| December 31, 2012 | 28.58M |
| December 31, 2011 | 22.86M |
| December 31, 2010 | 27.96M |
| Date | Value |
|---|---|
| December 31, 2009 | 31.46M |
| December 31, 2008 | 30.84M |
| December 31, 2007 | 24.22M |
| December 31, 2006 | 54.99M |
| December 31, 2005 | 11.32M |
| December 31, 2004 | 11.47M |
| December 31, 2003 | 8.128M |
| December 31, 2002 | 7.509M |
| December 31, 2001 | 6.985M |
| December 31, 2000 | 6.887M |
| December 31, 1999 | 6.403M |
| December 31, 1998 | 5.90M |
| December 31, 1997 | 4.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
34.64M
Minimum
2019
80.23M
Maximum
2023
50.52M
Average
49.06M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Stryker Corp | 1.388B |
| Globus Medical Inc | 124.01M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |